Why the study?
Does catheter ablation for atrial fibrillation provide similar long-term freedom from arrhythmia in patients with apical hypertrophic cardiomyopathy compared to non-HCM controls and septal HCM patients?
Does catheter ablation for atrial fibrillation provide similar long-term freedom from arrhythmia in patients with apical hypertrophic cardiomyopathy compared to non-HCM controls and septal HCM patients?
Catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy has worse long-term outcomes compared to non-HCM patients, but similar outcomes to those with septal HCM.
No takes yet. Share an insight, caveat, or question.
Apical HCM ablation may warrant cautious counseling on recurrence risk; leaves open need for prospective validation of subtype-specific strategies.
Roh et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: